Diagnostic Utility of CD14, CD33, CD123, and MPO Immunostains in Myelomonocytic Neoplasms

被引:0
|
作者
Rollins-Raval, M. A. [1 ]
Garcia, C. F. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1426
引用
收藏
页码:319A / 319A
页数:1
相关论文
共 50 条
  • [21] Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells
    Hauswirth, A. W.
    Florian, S.
    Printz, D.
    Sotlar, K.
    Krauth, M. -T.
    Fritsch, G.
    Schernthaner, G. -H.
    Wacheck, V.
    Selzer, E.
    Sperr, W. R.
    Valent, P.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (01) : 73 - 82
  • [22] POTENT LYSIS OF AML BLASTS BY TRILYTE SPM-2 WITH DUAL-TARGETING OF CD33 AND CD123 IN COMBINATION WITH SUBSETS OF NK CELLS
    Maier, C. P.
    Heubach, F.
    Herrmann, S.
    Kuemmerle, P.
    Braciak, T. A.
    Fenn, N.
    Schele, A.
    Schubert, I.
    Hopfner, K. P.
    Krupka, C.
    Subklewe, M.
    Aigner, M.
    Mackensen, A.
    Lengerke, C.
    Fey, G. H.
    Peipp, M.
    Lang, P.
    Oduncu, F.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S65 - S65
  • [23] Dual-Targeting CD33/CD123 NANOBODY ® T Cell Engager Targeting Leukemia Blasts and Stem/Progenitor Cells in Relapsed AML
    Zeng, Zhihong
    Roobrouck, Annelies
    Deschamps, Geert
    Bonnevaux, Helene
    Guerif, Stephane
    De Brabandere, Veronique
    Celine, Amara
    Jonckheere, Eline
    Virone-Oddos, Angela
    Chiron, Marielle
    Dullaers, Melissa
    Konopleva, Marina Y.
    BLOOD, 2023, 142
  • [24] Differences in CD33 intensity between various myeloid neoplasms
    Jilani, I
    Estey, E
    Huh, Y
    Joe, Y
    Manshouri, T
    Yared, M
    Giles, F
    Kantarjian, H
    Cortes, J
    Thomas, D
    Keating, M
    Freireich, E
    Albitar, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 560 - 566
  • [25] Diagnostic Value of CD33 by Immunohistochemistry in Leukemia Cutis
    Ma, L.
    Kim, D. S. L.
    Cutlan, J.
    Ross, C.
    Lim, M.
    Fullen, D.
    MODERN PATHOLOGY, 2009, 22 : 106A - 106A
  • [26] A DUAL TARGETING CD33/CD123 NANOBODY® T-CELL ENGAGER WITH POTENT ANTI-AML ACTIVITY AND A MANAGEABLE SAFETY PROFILE
    Dullaers, Melissa
    Deschamps, Geert
    Bonnevaux, Helene
    Guerif, Stephane
    De Brabandere, Veronique
    Amara, Celine
    Brige, Ann
    Dejonckheere, Eline
    Virone-Oddos, Angela
    Chiron, Marielle
    Roobrouck, Annelies
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1242 - A1242
  • [27] Diagnostic Value of CD33 by Immunohistochemistry in Leukemia Cutis
    Ma, L.
    Kim, D. S. L.
    Cutlan, J.
    Ross, C.
    Lim, M.
    Fullen, D.
    LABORATORY INVESTIGATION, 2009, 89 : 106A - 106A
  • [28] CD14, CD13, CD33 expression and interleukin-1 synthesis levels in not sorted and flow cytometric sorted cultured human macrophages
    Voiculescu, C
    Avramescu, C
    Radu, E
    JOURNAL OF LEUKOCYTE BIOLOGY, 1996, : 129 - 129
  • [29] MP0533: A Multispecific Darpin CD3 Engager Targeting CD33, CD123, and CD70 for the Treatment of AML and MDS Designed to Selectively Target Leukemic Stem Cells
    Bianchi, Matteo
    Reichen, Christian
    Fischer, Stefanie
    Grubler, Yvonne
    Eggenschwiler, Aline
    Marpakwar, Rajlakshmi
    Looser, Thamar
    Spitzli, Patricia
    Herzog, Christel
    Villemagne, Denis
    Kaufmann, Yvonne
    Auge, Alienor
    Hanggi, Martin
    Ali, Waleed
    Lekishvili, Tamara
    Frasconi, Teresa
    Wullschleger, Stephan
    Zitt, Christof
    Franchini, Marco
    Croset, Amelie
    Watson, Randall
    Kirkin, Vladimir
    Luethi, Ursina
    Ochsenbein, Adrian
    Riether, Carsten
    Steiner, Daniel
    Leupin, Nicolas
    Goubier, Anne
    BLOOD, 2022, 140 : 2251 - 2252
  • [30] Expression of the target receptor CD33 on CD34+/CD38-/CD123+AML stem cells.
    Hauswirth, AW
    Florian, S
    Krauth, MT
    Printz, D
    Fritsch, G
    Sotlar, K
    Schernthaner, GH
    Wacheck, V
    Selzer, E
    Sperr, WR
    Valent, P
    BLOOD, 2003, 102 (11) : 249B - 250B